Dr Darrin M Disley Obe

Dr. Darrin M Disley OBE is a seasoned leader in the biotechnology and healthcare sectors, currently serving as a Non-Executive Director at Roquefort Therapeutics plc and an Advisory Board Member at Sana Capital. As the CEO, Director, and Investor at Mogrify, Dr. Disley drives corporate strategy and governance for a company specializing in innovative cell conversion technology. Additionally, Dr. Disley serves as Chairman of Celixir, a regenerative medicine firm, and is the Principal and Founder of the Carpe Diem Investment Fund. Past roles include Chair of Trustees for Footprint Cafes and various honorary positions at the University of Salford and the University of Cambridge. Dr. Disley holds a PhD in Biotechnology from the University of Cambridge and has received an honorary Doctor of Science degree from the University of Salford.